Corcept Therapeutics
Corcept is seeking a Senior Manager, Development Systems to lead and scale innovative solutions and data integrations across clinical development applications, including Medidata Rave CTMS and Veeva eTMF. This pivotal role involves partnering with cross-functional teams to translate business needs into scalable technical solutions while ensuring compliance and data integrity. The position serves as the subject matter expert for development systems, driving organizational change management and operational excellence across clinical operations.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
1998
Corcept Therapeutics is a biopharmaceutical company that discovers and develops medicines that modulate the glucocorticoid receptor to treat disorders driven by excess cortisol. The company commercialized Korlym (mifepristone) for hyperglycemia secondary to endogenous Cushing’s syndrome and is advancing next‑generation, selective GR modulators (for example, relacorilant) through clinical development. Corcept combines translational science, clinical trials, and commercial capabilities to target endocrine and oncology indications where cortisol signaling contributes to disease. The company is headquartered in Menlo Park, California.
CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT
8 hours ago
REMINDER: Corcept Therapeutics Incorporated Investors With Significant Losses Must Act By April 21, 2026
1 day ago
Corcept Therapeutics Lawsuit: CORT Investors Face Losses After FDA Rejection and Alleged Misleading Statements
7 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Corcept Therapeutics.
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm – Company Announcement - FT.com
12 hours ago